Wilmington Funds Management’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
$2.58M Buy
128,671
+15,450
+14% +$354K 0.26% 110
2014
Q1
$3.08M Buy
113,221
+2,000
+2% +$53.1K 0.33% 96
2013
Q4
$2.31M Buy
111,221
+660
+0.6% +$12.4K 0.23% 128
2013
Q3
$2.02M Buy
110,561
+1,300
+1% +$23.5K 0.19% 150
2013
Q2
$1.82M Buy
+109,261
New +$1.74M 0.17% 155

Other funds holding AUXL

Wilmington Funds Management's AUXL Position: Q2 2014 in Review

Wilmington Funds Management increased its AUXILIUM PHARAMCEUTICALS INC (AUXL) stake by 14% in Q2 2014, buying an estimated $354K and bringing the position to 128,671 shares worth $2.58M. The position accounts for 0.26% of the portfolio, ranked #110.

Wilmington Funds Management first reported a position in AUXL in Q2 2013 and has held it in 5 quarters since. The position peaked at $3.08M in Q1 2014. 152 funds tracked by Wall St. Rank hold AUXL as of Q2 2014.

  • Wilmington Funds Management held 128,671 shares of AUXILIUM PHARAMCEUTICALS INC worth $2.58M as of Q2 2014.
  • Wilmington Funds Management bought 15,450 AUXILIUM PHARAMCEUTICALS INC shares in Q2 2014, an estimated $354K.
  • AUXILIUM PHARAMCEUTICALS INC made up 0.26% of Wilmington Funds Management's portfolio in Q2 2014, its #110 holding.
  • Wilmington Funds Management first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and has held it in 5 quarters since.
  • Wilmington Funds Management's AUXILIUM PHARAMCEUTICALS INC position peaked at $3.08M in Q1 2014.
  • 152 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.